search
Back to results

Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer (CRYO1)

Primary Purpose

Breast Neoplasms, Prostate Cancer, Nail Diseases

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Frozen Glove
Sponsored by
Institut Paoli-Calmettes
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Breast Neoplasms focused on measuring Neoplasm, breast Neoplasm, docetaxel, Glove

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with hormono-resistant breast cancer or metastatic prostate cancer treated by chemotherapy with Taxotere®.
  • Patients aged 18 and older
  • Nail toxicity < grade 2 (CTC-AE version 3.0)
  • Informed patients with signed consent

Exclusion Criteria:

  • History of treatment with taxane
  • Raynaud syndrome
  • Distal metastasis in superior extremity
  • Nail diseases
  • Distal arteriopathy
  • Cold intolerance
  • Peripheral neuropathy>=2
  • Pregnancy, breast feeding
  • Unable to give informed consent
  • Unable to have a medical follow-up for social, geographical, family or psychological reasons

Sites / Locations

  • Institut PAOLI-CALMETTES

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Without Glove

With Glove

Arm Description

Patients do not use frozen glove during chemotherapy with Taxotere®

Patients use frozen glove during chemotherapy with Taxotere®

Outcomes

Primary Outcome Measures

Number of patients treated by Taxotere® with nail toxicity >= 2 (CTC-AE version 3.0)

Secondary Outcome Measures

Number of day between inclusion and apparition of nail toxicity
Necessity of local care, existence of pains
Tolerance and compliance for the frozen glove

Full Information

First Posted
June 19, 2009
Last Updated
September 13, 2011
Sponsor
Institut Paoli-Calmettes
search

1. Study Identification

Unique Protocol Identification Number
NCT00925418
Brief Title
Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer
Acronym
CRYO1
Official Title
Randomized Trial Evaluating the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Patient Treated for Breast or Prostate Cancer.
Study Type
Interventional

2. Study Status

Record Verification Date
September 2011
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
September 2010 (Actual)
Study Completion Date
July 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut Paoli-Calmettes

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Taxotere® can induce nails changes like dyschromia, hematoma, lines of Beau-Reil (signing the stop of the epithelial proliferation), abscess, or pain. In this context, this randomized, monocentric phase III trial evaluates the cryotherapy, using frozen glove, in the prevention of nails toxicity induced by Taxotere® in patient treated for breast or prostate cancer. Primary objective: Demonstrate a reduction of the nails toxicity using frozen glove during chemotherapy with Taxotere®. Secondary objectives: Analysis of time of protection against onycholysis Estimation of the efficiency of cryotherapy, and impact on quality of life Tolerance and compliance of the frozen glove

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Neoplasms, Prostate Cancer, Nail Diseases
Keywords
Neoplasm, breast Neoplasm, docetaxel, Glove

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
168 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Without Glove
Arm Type
No Intervention
Arm Description
Patients do not use frozen glove during chemotherapy with Taxotere®
Arm Title
With Glove
Arm Type
Experimental
Arm Description
Patients use frozen glove during chemotherapy with Taxotere®
Intervention Type
Procedure
Intervention Name(s)
Frozen Glove
Intervention Description
Using frozen glove during chemotherapy with Taxotere®
Primary Outcome Measure Information:
Title
Number of patients treated by Taxotere® with nail toxicity >= 2 (CTC-AE version 3.0)
Time Frame
4 months
Secondary Outcome Measure Information:
Title
Number of day between inclusion and apparition of nail toxicity
Time Frame
4 months
Title
Necessity of local care, existence of pains
Time Frame
4 months
Title
Tolerance and compliance for the frozen glove
Time Frame
4 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with hormono-resistant breast cancer or metastatic prostate cancer treated by chemotherapy with Taxotere®. Patients aged 18 and older Nail toxicity < grade 2 (CTC-AE version 3.0) Informed patients with signed consent Exclusion Criteria: History of treatment with taxane Raynaud syndrome Distal metastasis in superior extremity Nail diseases Distal arteriopathy Cold intolerance Peripheral neuropathy>=2 Pregnancy, breast feeding Unable to give informed consent Unable to have a medical follow-up for social, geographical, family or psychological reasons
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carole TARPIN, MD
Organizational Affiliation
Institut Paoli-Calmettes
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut PAOLI-CALMETTES
City
Marseille
Country
France

12. IPD Sharing Statement

Links:
URL
http://www.institutpaolicalmettes.fr
Description
Official web site of the sponsor

Learn more about this trial

Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer

We'll reach out to this number within 24 hrs